Mediz - Growmore First Addendum Commercial Agreement - 23 Jan 2024

You might also like

Download as pdf or txt
Download as pdf or txt
You are on page 1of 3

First Supplemental Agreement

This First Supplemental Agreement to the Distribution Agreement dated 14th December, 2023
(hereinafter referred to as the “First Supplemental Agreement”) is executed on 23th January,
2024 (hereinafter referred to as “Amendment Effective Date”).

BY AND BETWEEN

GROWMORE PHARMACEUTICAL LLC, a distributor, constituted under the provisions of


the Ministry Of Health-UAE, and having its store at Lootah Warehouse 2, Dubai Investment Park
Dubai, UAE and it is duly represented by its Managing Director Mr. Adeeb Koppilath (hereinafter
called “GROWMORE or DISTRIBUTOR ”)

AND

M/s MEDIZ PHARMA, a company formed under the provision of the Companies Act 2006,
having it’s Registered Office at X/698, Athikkattukulangara, Palamel, Mavelikkara, Alappuzha,
Kerala 690528 represented by its Managing Director, Mr. Manu George (hereinafter referred to as
“MEDIZ or MAH” )which term shall mean and include its successors-in-interest and assigns

GROWMORE and MEDIZ are hereinafter individually referred to as “Party” and collectively
referred to as “Parties”.

WHEREAS:

i. GROWMORE and MEDIZ have entered into a Distribution Agreement dated 14th
December, 2023 (the “Agreement”) in relation to Manufacture and Supply of the Products
(as defined in the “Agreement”) by MEDIZ and supply thereof to GROWMORE on the
terms and conditions more particularly set out in the Agreement.

ii. The Parties accordingly wish to amend the Agreement on the terms and conditions set
forth in this First Supplemental Agreement.

NOW THEREFORE, in consideration of the premises and mutual agreement, covenants and
conditions hereinafter set forth, the Parties agree, and covenant as follows:

Page 1 of 3
1. AMENDMENT

1.1 With effect from the Amendment Effective Date, the Parties have agreed to amend the
products in ANNEX I as below:

SL PRODUCT Description
Description Primary
Primary
pack
pack MOQ MOQ FOB
Ex factory
Price (inPrice
Nr NAME USD)
(in USD)
1 Feraldam Heme Iron ALU-ALU 10000 packs of 20’s 4.95 USD /pack
Polypeptide Tablets ( 10’s blister x 2)
2 Trimecare Each sachet (15g) 10 x 15 gm 5000 pack 2.93 USD/pack
contains: L- sachets
Arginine 5 g Zinc
(as zinc sulfate) 10
mg Folic Acid 400
mcg
3 Laxoshot Polyethylene glycol 10 x 17 gm 5000 pack 2.57 USD/pack
3350 17 gm sachets
4 Maglyphos Magnesium 3 x 10’s 5000 pack 3.24 USD/pack
Glycerophosphate Alu/Alu
equivalent to chewable and
Magnesium 97.2mg swallowable
tablets
5 Deair Simethicone 30 ml drops 5000 pack 0.85 USD/pack
40mg/0.6ml

Exhibit 1: Products, Ex Factory Prices, Purchase Minimum Units Forecast

Forecast

First Year 10,000 Packs

Second year 20,000 Packs

Third year 30,000 Packs

Exhibit 2: Trademarks, Packaging

All brands listed above or changed will be owned by Mediz Pharma.


All packaging specification will be pre-approved by the distributor before production

Page 2 of 3
2. GENERAL PROVISIONS

2.1 Save and except as expressly set forth in this First Supplemental Agreement, all other
provisions and terms and conditions of the Agreement shall remain unaltered and continue
to have full force in accordance with provisions contained in the Agreement.

2.2 This First Supplemental Agreement along with the Agreement constitutes the entire
agreement between the Parties in respect of the subject matter more particularly set out in
the Agreement.

IN WITNESS WHEREOF, the Parties hereto have caused this First Supplemental Agreement to
be executed by their duly authorized representatives.

SIGNED AND DELIVERED SIGNED AND DELIVERED


by the within named by the within named
Growmore Pharmaceutical LLC Mediz Pharma
__________________________________ _____________________________________

Name: Adeeb Koppilath Name: Mr Manu George


Title: Managing Director Title: Managing Director

Page 3 of 3

You might also like